Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients

NCT01322789 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01322789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01322789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients
Lead sponsor
University of Sao Paulo
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2008
Completion date
December 31, 2015
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, insulin-dependent